DEHP‐plasticised PVC: relevance to blood services*

Transfusion Medicine - Tập 21 Số 2 - Trang 73-83 - 2011
Joshua N. Sampson1, Dirk de Korte2
1Department of Quality Assurance, Welsh Blood Service, Pontyclun, Mid Glamorgan, UK
2Sanquin Blood Supply, Department Product and Process Development and Sanquin Research, Amsterdam, The Netherlands

Tóm tắt

Phthalates are the most widely used plasticisers in the world and have been in medical use since 1955. Di(2‐ethylhexyl)phthalate (DEHP) is present in many industrial and domestic products, and is a common plasticiser used in blood bags and tubing sets. Concerns have been raised by environmental groups that DEHP exposure may result in gender birth defects and the feminisation of boys although there were no studies performed of intravenous exposure to DEHP on higher mammals or humans which report similar effects.

This article reports on the toxicology of DEHP and considers concerns regarding its use in the context of transfusion medicine. The benefits of using DEHP are evaluated and the use of alternative plasticisers to DEHP is explored. The article reports on international and European regulatory recommendations for DEHP use in transfusion medicine and examines the impact of legislation on the medical devices and blood industries. The article also reviews labelling considerations for blood components and offers some guidance for blood establishments in respect of DEHP use.

Từ khóa


Tài liệu tham khảo

Aubuchon J.P., 1988, The effect of plaslticizer Di‐2‐ethylhexyl phthalate on the survival of stored RBCs., Blood, 71, 448, 10.1182/blood.V71.2.448.448

10.1093/toxsci/kfq147

CEN (European Committee for Standardization)(2010)prEN 15986 Symbol for use in the labelling of medical devices–requirements for labelling of medical devices containing phthalates[WWW document]. URLhttps://www.cen.eu/cen/Sectors/Sectors/Healthcare/Pages/default.aspx(Accessed 15/7/10).

10.1080/01926230152500040

Eucomed(2006)Eucomed position on the use of DEHP‐plasticized PVC in medical products[WWW document]. URLhttp://www.eucomed.be/upload/pdf/tl/2006/portal/publications/position_papers/2006‐09_dehp‐pvc_in_medical_products.pdf(Accessed 15/7/10).

European Commission(1993)Official Journal of the European Union. Council Directive 93/42/EEC of 14 June 1993 concerning medical devices[WWW document]. URLhttp://eurlex.europa.eu/LexUriServ/LexUriServ.do?uri=CELEX:31993L0042:EN:HTML(Accessed 15/7/10).

European Commission(1967)Council Directive 67/548/EEC of 27 June 1967 on the approximation of laws regulations and administrative provisions relating to the classification packaging and labelling of dangerous substrates. Annex 1[WWW document]. URLhttp://www.reach‐compliance.eu/english/legislation/docs/launchers/launch‐annex‐1‐67‐548‐EEC.html(Accessed 19/7/10).

European Commission Scientific Committee on Medicinal Products and Medical Devices (SCMPMD)(2002)Opinion on Medical Devices Containing DEHP Plasticised PVC; Neonates and Other Groups Possibly at Risk from DEHP Toxicity[WWW document]. URLhttp://ec.europa.eu/health/ph_risk/committees/scmp/documents/out43_en.pdf(Accessed 15/7/10).

European Commission Scientific Committee on Toxicity Ecotoxicity and the Environment (CSTEE)(2004)Opinion on the result of a second Risk Assessment of bis(2‐ethylhexyl)phthalate(DEHP) Human Health Part[WWW document]. URLhttp://ec.europa.eu/health/ph_risk/committees/sct/documents/out214_en.pdf(Accessed 16/7/10).

European Commission(2007a)Official Journal of the European Union. Directive 2007/47/EC Of The European Parliament And Of The Council of 5 September 2007[WWW document]. URLhttp://eur‐lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2007:247:0021:0055:EN:PDF(Accessed 15/7/10).

European Commission Scientific Committee on Emerging and Newly‐Identified Health Risks (SCENIHR)(2007b)Preliminary report on the safety of medical devices containing DEHP‐plasticized PVC or other plasticizers on neonates and other groups possibly at risk[WWW document]. URLhttp://ec.europa.eu/health/ph_risk/committees/04_scenihr/docs/scenihr_o_008.pdf(Accessed 15/7/10).

European Commission. European Chemicals Bureau.(2008a)EUR 23384 EN/2 European Union Risk Assessment Report bis (2‐ethylhexyl) phthalate (DEHP) Volume 80. Luxembourg: Office for Official Publications of the European Communities 2008 EUR–Scientific and Technical Research series–ISSN 1018–5593[WWW document]. URLhttp://ecb.jrc.ec.europa.eu/documents/Existing‐Chemicals/RISK_ASSESSMENT/REPORT/dehpreport042.pdf(Accessed 16/7/10).

European Commission Scientific Committee on Emerging and Newly‐Identified Health Risks (SCENIHR).(2008b)Opinion on the safety of medical devices containing DEHP‐plasticized PVC or other plasticizers on neonates and other groups possibly at risk[WWW document]. URLhttp://ec.europa.eu/health/ph_risk/committees/04_scenihr/docs/scenihr_o_014.pdf(Accessed 15/7/10).

European Food Safety Authority, 2005, Opinion of the scientific panel on food additives, flavourings, processing aids and materials in contact with food (AFC) on a request from the commission related to bis(2‐ethylhexyl)phthalate (DEHP) for use in food contact materials. Question N° EFSA‐Q‐2003‐191., EFSA Journal, 243, 1

FDA.U.S. Food and Drug Administration (2002a)Medical devices made with polyvinylchloride (PVC) using the plasticiser di‐(2‐ethylhexyl) phthalate (DEHP). Draft guidance for industry and FDA Draft released for comment FDA Centre for Devices and Radiological Health.

FDA.U.S. Food and Drug Administration (2002b)Safety assessment of di(2‐ethylhexyl) phthalate (DEHP) released from PVC medical devices FDA Centre for Devices and Radiological Health.

10.1093/toxsci/58.2.350

Health Canada Expert Advisory Panel On DEHP In Medical Devices(2002) Final Report 2002 January 11 Health Canada. Ottawa Canada[WWW document]. URLhttp://www.hc‐sc.gc.ca/dhp‐mps/alt_formats/hpfb‐dgpsa/pdf/md‐im/sapdehp_rep_gcsdehp_rap_2002‐01‐11‐eng.pdf(Accessed 14/7/10).

Health Canada.Medical Devices Bureau Therapeutic Products Directorate Health Products and Food Branch (2002)DEHP in Medical Devices: an exposure and toxicity assessment.

10.1046/j.1537-2995.1991.31191096180.x

10.1111/j.1423-0410.1985.tb00162.x

10.1016/S0140-6736(70)92734-0

10.1016/j.ijheh.2005.07.001

Labow R.S., 1987, The effect of the plasticizer di(2‐ethylhexyl)phthalate on red cell deformability., Blood, 70, 319, 10.1182/blood.V70.1.319.319

10.1016/0041-008X(87)90011-1

10.1053/jpsu.2000.19249

10.1097/00005176-200410000-00008

10.1289/ehp.01109229

10.1111/j.1423-0410.1987.tb05066.x

10.1046/j.1537-2995.1978.18579036383.x

10.1046/j.1537-2995.1984.24685066808.x

Schilling K. Gembardt C.&Hellwig J.(2001)Di‐2‐ethylhexyl phthalate‐two generation reproduction toxicity study in Wistar rats by continuous dietary administration. Laboratory Project Identification 70R049/97139.Department of Experimental Toxicology and Ecology BASF Aktiengesellschaft 67056 Ludwigshafen. Report to the European Council for Plasticizers and Intermediates CEFIC Brussels Belgium.

10.1046/j.1537-2995.1985.25586020115.x

10.1016/S0045-6535(97)00195-1

10.1016/j.ijheh.2006.11.009

10.1016/j.ijheh.2007.01.037

Wolfe G.W.&Layton K.A.(2003)Multigeneration reproduction toxicity study in rats (unaudited draft): diethylhexylphthalate: multigenerational reproductive assessment when administered to sprague‐dawley rats in the diet. TherImmune Research Corporation (Gaithersburg Maryland) TRC Study n°7244‐200 2003[WWW document]. URLhttp://ntp.niehs.nih.gov/index.cfm?objectid=21FA3229‐F1F6‐975E‐78052E38CE3F314C(only abstract Accessed 17/7/10).